Human pancreatic ribonuclease (HP-RNase 3 ,RNase Human pancreatic ribonuclease (HP-RNase) has 1, or secretory-type RNase; EC 3.27.1.5) catalyzes the considerable promise as a therapeutic agent. Struc-cleavage of RNA specifically on the 3-side of pyrimiture-function analyses of HP-RNase have been im-dine bases. HP-RNase is a member of the family of peded by the difficulty of obtaining the enzyme from secretory ribonucleases, some of which affect the its host. Here, a gene encoding HP-RNase was de-growth and differentiation of mammalian cells (1,2). signed, synthesized, and inserted into two expression For example, angiogenin promotes blood vessel formavectors that then direct the production of HP-RNase tion (3,4). Bovine seminal ribonuclease (5,6) and oncoin Saccharomyces cerevisiae (fused to either an un-nase from the frog Rana pipiens (7,8) are potent antitumodified or a modified a-factor pre-pro segment) or mor agents.
is glycosylated extensively (12). Still, the amino acid All enzymes for molecular biology were from Boehringer Mannheim (Mannheim, Germany), except sequence of HP-RNase has been determined (13). The cDNA that codes for HP-RNase has been cloned and Acc65I (Promega; Madison, WI) and MscI (New England Biolabs; Beverly, MA). Reagents for DNA syntheshown to consist of 1620 base pairs, including an open reading frame encoding the 128-residue mature protein sis were from Applied Biosystems (Foster City, CA) except for acetonitrile, which was from Baxter Healthfollowing a 28-residue signal sequence (14) . Although no other structural information is available about HP-care (McGaw Park, IL). Agarose was from Life Technologies (Gaithersburg, MD) and Spectra Por dialysis RNase, its amino acid sequence is 70% identical to that of bovine pancreatic ribonuclease A (RNase A), which membrane (3500 M r cut off) was from Spectrum Medical Industries (Los Angeles, CA). CM Sepharose CL6B has been the object of much seminal work in biological chemistry (15) (16) (17) (18) (19) (20) . This homology makes it possible to cation-exchange resin and Mono-S HR 5/5 column were from Pharmacia LKB Biotechnology (Uppsala, Swespeculate on the roles of particular amino acid residues in the structure and function of HP-RNase. Still, test-den). Protein-Pak CM 8 HR A-1 cation-exchange column and the two 510-pump HPLC system with a 996 ing such speculations requires the use of a heterologous expression system for HP-RNase. Recently, D'Alessio Photodiode Array detector were from Millipore-Waters (Milford, MA). and co-workers reported the expression of a gene that codes for HP-RNase in Chinese hamster ovary cells Yeast minimal medium (SD) was prepared as described (26) . Bacterial terrific broth was prepared as (21) . The resulting HP-RNase was a complex mixture of unmodified and glycosylated forms.
described (27) . The different variations on standard media were as we described previously (22). Bacto To enable structure-function analyses of HP-RNase, we have developed two microbial expression systems. yeast extract, Bacto tryptone, Bacto peptone, Bacto agar, and Bacto Yeast nitrogen base without amino A synthetic gene that codes for HP-RNase was designed and inserted into plasmids so as to direct the produc-acids were from Difco (Detroit, MI).
Isopropyl-b-D-thiogalactopyranoside (IPTG), dithiotion of HP-RNase in Saccharomyces cerevisiae or Escherichia coli. The yeast system uses the pWL vector, treitol (DTT), oxidized glutathione (GSSG), and reduced glutathione (GSH) were from Boehringer Mannwhich we had used previously to produce RNase A (22). The bacterial system uses a pET vector (23) . Recombi-heim. Poly(cytidylic acid) [poly(C)] used for zymogram electrophoresis was from Pharmacia. Poly(C) and cytinant HP-RNase isolated from yeast (reHPR.Y) was a heterogeneous population of unmodified and modified dine 2,3-cyclic phosphate (C ú p) used in kinetic assays were from Sigma Chemical (St. Louis, MO). Re-(that is, glycosylated or not fully processed) enzyme that was recoverable at 0.1-0.2 mg/liter of culture. Re-agents for polyacrylamide gels electrophoresis in the presence of sodium dodecyl sulfate (SDS-PAGE) were combinant HP-RNase isolated from bacteria (reHPR.B) was a homogeneous enzyme that was recoverable at 1 from Bio-Rad (Richmond, CA). All other chemicals were of reagent grade or better and were used without furmg/liter of culture. The steady-state kinetic parameters exhibited by reHPR.B were similar to those of the un-ther purification. modified enzyme isolated from human pancreas. Although the yeast system provides no advantage over Methods the existing mammalian system (21) other than experimental ease, the bacterial system is the first that Reactions involving restriction enzymes, T4 DNA ligase or T4 polynucleotide kinase were performed in the allows for the rapid isolation of unmodified HP-RNase in yields appropriate for structure-function analyses. buffers provided by their suppliers. DNA restriction fragments were purified from bands in agarose (0.75%, w/v) gels with a GeneClean II kit from BIO-101 (La
EXPERIMENTAL PROCEDURES
Jolla, CA).
Materials
Oligonucleotides were synthesized on an Applied Biosystems 392 DNA/RNA synthesizer by using the bUnmodified HP-RNase was purified from human pancreas as described (12). RNase A was from Biozyme cyanoethyl phosphoramidite method (28) and purified by using both oligo purification cartridges (Applied Bio-(Blaenovon, England).
S. cerevisiae strain BJ2168 (MAT a prc1-407 prb1-systems) and PAGE as described (26) . DNA sequences were determined with the T7 sequencing kit from Phar-1122 pep4-3 leu2 trp1 ura3-52) was from the Yeast Genetic Stock Center (Berkeley, CA). Yeast expression macia. Oligonucleotide-mediated site-directed mutagenesis was performed by the method of Nakamaye and vector pWL is a shuttle vector designed to facilitate the genetic manipulations required in protein engineering Eckstein (29) using a kit from Amersham Life Science (Arlington Heights, IL). Other manipulations of DNA (22, 24, 25) . E. coli strain BL21(DE3) [F 0 , ompT, r B 0 , m B 0 ] (23) and pET22b(/) were from Novagen (Madi-were performed as described (26, 27) . SDS-PAGE was performed at room temperature in son, WI). gels (0.8 1 8 1 10 cm) containing polyacrylamide (15%, is an isoschizomer of KpnI) and SalI, and the gene was cloned into M13mp19 that had been digested with w/v) and SDS (0.1%, w/v) as described (30) , except using a Bio-Rad Protean II dual slab cell model apparatus. (31) . Ultraviolet and visible absorbance measure-transformed with pWL can be selected by recovery of ments were made with a Cary Model 3 spectrophotome-tryptophan (TRP1) or leucine (LEU2-d) prototrophy. In ter (Varian, Palo Alto, CA) equipped with a Cary tem-YEpHPR.1, the production of HP-RNase fused to the perature controller. Amino acid sequences were a-factor pre-pro segment is under the transcriptional determined by using a Beckman LF-3000 sequencer.
control of the hybrid ADH2-GAPDH promoter, which Design of a synthetic gene for HP-RNase. Eight oli-is derepressed by depletion of fermentable carbon gonucleotides were designed such that their annealing sources (35), and of the GAPDH terminator sequence. and ligation would result in a gene ( Fig. 1 ) that codes To create plasmid YEpHPR.2, oligonucleotide MR5 (5-for HP-RNase (13). 5 The design had three additional TACCTTTGGATAAAAGAGAGGCTGAAGCTGAAGobjectives: (i) to allow for the expression of the gene CTGAAGCTAAGGAATCTCGAGCT-3) was used to from yeast expression plasmid pWL, (ii) to distribute insert an 18-bp sequence encoding a (Glu-Ala) 3 nonaunique restriction endonuclease recognition sites peptide at the C terminus of the a-factor pre-pro segthroughout the gene, and (iii) to use codons that max-ment (36). This nonapeptide is recognized by the proteimize protein production in S. cerevisiae. These objec-ase product of the STE13 gene product. This protease tives were accomplished by (i) adding a KpnI and a acts with the proteases encoded by genes KEX1 and SalI site to the 5 and 3 termini of the gene to enable KEX2 to process the a-factor pre-pro segment. the ligation of the gene into plasmid pWL, (ii) identiConstruction of plasmid pET22.HPR. An MscI site fying five unique restriction sites that could be incorpo-was generated at the 5 termini of the HP-RNase gene rated into the HP-RNase coding region using the SI-of M13mp19.HPR by mutagenesis using oligonucleo-LENT program from the Genetics Computer Group tide MR4 (5-CGGTACCTTTGGATATGGCCAATT-(Madison, WI), and (iii) using those codons that are AATCTCGAGCT-3). The resulting MscI/SalI fragmost prevalent in S. cerevisiae (32) . ment was band purified, and inserted into E. coli exSynthesis of the gene coding for HP-RNase. A gene pression plasmid pET22b(/) that had been digested that codes for HP-RNase was constructed by a method with MscI and SalI, to yield plasmid pET22.HPR. similar to that described previously (33, 34) . Briefly, Plate assay for ribonuclease activity. We and others eight overlapping oligonucleotides coding for both have used plate assays to measure the ability of a mistrands of the HP-RNase gene were synthesized chemi-crobe to secrete an active ribonuclease (22, 25, 37, 38) . A cally. The oligonucleotides, except those that constitute plate assay was used to test the ability of pET22.HPR, the two 5 termini of the gene, were phosphorylated YEpHPR.1, and YEpHPR.2 to direct the secretion of with the enzyme T4 polynucleotide kinase. Each pair active HP-RNase. of complementary oligonucleotides (that is, 1 and 1c, 2 For S. cerevisiae, an aliquot (1 ml) of a culture of and 2c, 3 and 3c, and 4 and 4c) were annealed to gener-BJ2168 carrying pWL, YEpWL.RNase A (22), ate four fragments, which were then ligated using T4 YEpHPR.1, or YEpHPR.2 and grown overnight in DNA ligase. The assembled ligation product was gel S4%D-leu medium was placed on a plate of YEP1%D purified and amplified by the polymerase chain reac-containing Bacto agar (2%, w/v) and yeast RNA (2 mg/ tion using oligonucleotides 1d (5-CGACTGGGTACC-ml). The plates were incubated at 30ЊC for 3 days to TTTGGATAAAAGAAA-3) and 4d (5-CGACTGCTC-allow for ribonuclease to be produced and for its enzy-GACTTAAGAATCTTCAAC-3) as primers. The re-matic activity to be manifested. sulting PCR product was digested with Acc65I (which For bacteria, an aliquot (1 ml) of a culture of BL21(DE3) carrying pET22b(/), pBXR (22), or pET22.HPR and grown overnight in LB medium con- 5 The amino acid sequence in Ref. 13 and Fig. 1 lacks the C-termitaining ampicillin (400 mg/ml) was placed on a plate of nal threonine residue that was deduced from the cDNA sequence (14) after our work had begun.
the same medium containing Bacto agar (1.5%, w/v), yeast RNA (2 mg/ml) and IPTG (1 mM). The plate was active fractions was assessed by SDS-PAGE and zymogram electrophoresis. incubated for 8 h at 37ЊC.
To assess ribonuclease activity, the plates were deProduction and purification of recombinant HPveloped by washing with aqueous perchloric acid (10%, RNase from E. coli (reHPR.B). A mid-log phase culv/v), which precipitates high molecular mass RNA. Col-ture of E. coli strain BL21(DE3) harboring plasmid onies that secrete active ribonuclease produced a clear-pET22.HPR in TB medium containing ampicillin (400 ing in an otherwise foggy background. mg/ml) was used to inoculate a larger culture (1 liter) of the same medium containing ampicillin (50 mg/ml). Zymogram electrophoresis. Zymogram electrophoresis was used to assess the ability of ribonucleases to The inoculated culture was shaken at 25ЊC until it reached late log phase (A 550 Å 1-2 O.D.) and was then cleave poly(C) (39). Briefly, zymogram electrophoresis was SDS-PAGE in a nonreducing gel containing po-induced to express the synthetic gene that codes for HP-RNase by the addition of IPTG to a final concentraly(C) (0.3 mg/ml). After electrophoresis, the SDS was extracted with aqueous isopropanol, and the gel was tion of 1 mM. Shaking at 25ЊC was continued overnight. incubated for 30 min at pH 8.0 to allow for the enzy-The cells were harvested by centrifugation for 20 min matic cleavage of poly(C). The gel was then stained at 10,000g at 4ЊC. with toluidine blue (0.2%, w/v) and destained with wa-
The cell pellet was resuspended in solubilization ter until regions in the gel containing ribonuclease ac-buffer (200 ml), which was 20 mM Tris-HCl buffer, pH tivity appeared as clear bands in a blue background.
7.8, containing urea (6 M), EDTA (1 mM), PMSF (0.2 mM), and DTT (20 mM). This suspension was shaken Zymogram spot assay. Zymogram spot assays were for 1 h at 37ЊC and then centrifuged for 20 min at used to assess rapidly the ribonuclease content of frac-10,000g and 4ЊC. The supernatant was retained and tions produced during ribonuclease purification and to the pellet was extracted again with 200 ml of solubilizaestimate the amount of RNase produced by the yeast tion buffer. expression system. The spot assay was performed as
The two supernatants were pooled together and described (22), except that torula yeast RNA type VI loaded onto a column (100 ml) of CM-Sepharose CL 6B (Sigma Chemical) was used instead of poly(C).
that had been equilibrated with 20 mM Tris-HCl, pH Production and purification of recombinant HP-7.8, containing urea (6 M) and DTT (2 mM). The loaded RNase from S. cerevisiae (reHPR.Y). reHPR.Y was column was washed with the same buffer (200 ml). HPpurified from S. cerevisiae strain BJ2168 harboring the RNase was eluted with a linear gradient of NaCl (0.00-plasmid YEpHPR.2. Transformed cells were stored as 0.50 M) in the same buffer. Fractions (5 ml) were col-070ЊC freezer stocks in glycerol (30%, w/v). Frozen cells lected and assayed for ribonuclease activity using zywere rejuvenated by plating onto 2 1 S4%D-Trp con-mogram electrophoresis. The fractions containing taining Bacto agar (2%, w/v) and incubating the re-RNase activity were pooled and dialyzed for 24 h at sulting plates at 30ЊC for 2 days. A liquid culture of 2 room temperature against 20 mM Tris-HCl buffer, pH 1 S4%D-Trp was inoculated with cells from the plate 7.8, containing NaCl (0.1 M), GSH (1 mM), and GSSG and shaken at 30ЊC until turbid. A liquid culture of (2 mM) to allow for the refolding and reoxidation of the 2 1 S4%D-Leu was then inoculated with the turbid sample. Additional dialysis against 20 mM Tris-HCl culture and grown until it was turbid. The resulting buffer, pH 7.8, was performed to remove the remaining culture was added to 2 1 S4%D-Leu medium (1 liter), salt and urea. The RNase was purified further by catwhich was then shaken at 30ЊC for 96 h.
ion-exchange chromatography on a Protein-pak CMCells were removed by centrifugation at 3000g for 10 8HR A-1 HPLC column. The elution was carried out min, and the supernatant was concentrated to 70 ml with a linear gradient (30 / 30 ml) of NaCl (0.00-0.20 with a Minitan ultrafiltration system (Millipore, MA) M) in 20 mM Tris-HCl buffer, pH 8.0. using a 5000 M r cutoff polysulfone membrane. Acetone
Determination of steady-state kinetic parameters. (to 60%, v/v) was added to the concentrate, and the Spectrophotometric assays (40) were used to determine resulting precipitate was collected by centrifugation at the kinetic parameters for the cleavage of poly(C) and 27,000g for 30 min. The precipitate was resuspended the hydrolysis of C ú p by the various ribonucleases. in a minimal volume of water and lyophilized. The lyophilysate was resuspended in and dialyzed exhaus-For C ú p, the concentration of enzyme was 0.1-0. 25 mM, the initial concentration of C ú p was 0.1-3 mM, tively against 25 mM sodium acetate buffer, pH 5.5. The dialysate was loaded onto a Mono-S cation-exchange and the activity was measured by recording the increase in absorbance at 296 nm [De 296 Å 516.4 M 01 cm 01 column that had been equilibrated with the same buffer. RNase was eluted with a linear gradient of NaCl (40)]. During assays of poly(C) cleavage, the concentration of enzyme was 5 nM, the initial concentration of (0.00-0.35 M) in 25 mM sodium acetate buffer, pH 5.5. Fractions were collected and assayed for ribonuclease poly(C) was 0.10-2.5 mg/ml, and the decrease in absorbance at 294 nm was monitored. All assays were activity with the zymogram spot assay. The purity of carried out at 25ЊC in 0.2 M sodium acetate buffer, pH the presence of a region coding for the (Glu-Ala) 3 nona-5.5, using 1-cm path length cells for C ú p and 0.2-peptide spacer in frame between the C-terminal Lyscm path length cells for poly(C). Steady-state kinetic Arg of the a-factor pre-pro segment and the N-termiparameters were obtained by nonlinear regression nal sequence of the HP-RNase gene. The resulting plasanalysis using the program Enzfitter (41).
mids were shown to be functional as follows. Together with pWL and YEpWL.RNase A (which served as negative and positive controls for the expression of a ribo-RESULTS nuclease), YEpHPR.1 and YEpHPR.2 were propagated Design and Construction of Synthetic Gene for HPin E. coli and conferred ampicillin resistance to transRNase formed cells. All four plasmids were also propagated in Eight overlapping oligonucleotides have been de-S. cerevisiae and allowed transformed cells to recover signed and synthesized such that their annealing and tryptophan and leucine prototrophies. BJ2168 S. cereligation result in a gene that codes for HP-RNase pro-visiae cells carrying YEpWL.RNase A, YEpHPR.1, or tein (13). Although the ligation product was designed YEpHPR.2, but not pWL, tested positive in the ribowith cohesive ends, we opted to amplify it to increase nuclease plate assay under low glucose conditions, indithe efficiency of subcloning. PCR amplification of the cating the capability of these constructions to express ligation product generated a fragment of appropriate active reHPR.Y. size (400 -450 bp). This fragment was digested with
The amounts of ribonuclease secreted by S. cerevisiae Acc65I and Sal I to generate cohesive ends and BJ2168 harboring plasmid YEpHPR.1, YEpHPR.2, and then subcloned into M13mp19, yielding plasmid YEpWL.RNase A were difficult to compare because M13mp19.HPR. The nucleotide sequence of the syn-each sample was glycosylated extensively. Instead, we thetic HP-RNase gene was found to be as expected compared the production of ribonuclease activity by us- (Fig. 1) .
ing a RNA zymogram spot assay as described (42) M NaCl. Analysis of this protein by SDS-PAGE and vine enzyme into the medium in a variety of forms due to inefficient removal of the leader sequence, extensive zymogram electrophoresis showed a single, active band with a mobility similar to that of commercial RNase A N-glycosylation, and mild O-linked glycosylation (22). The heterogeneity observed in HP-RNase is likely due (Fig. 2, lanes 3 and 5) . The isolated yield of reHPR.B, as estimated from measurements of protein concentrato similar occurrences. The isolated yield of reHPR.Y, as estimated from measurements of protein concentra-tion, was approximately 1 mg/liter of culture. The amino acid sequence of the five N-terminal residues of tion, was 0.1-0.2 mg/liter of culture.
the protein purified by HPLC was identical to that of enzyme isolated from human pancreas.
Expression and Purification of Recombinant HP-
RNase from E. coli Steady-State Kinetic Parameters Sequence analysis confirmed that pET22.HPR had been constructed as designed. E. coli cells carrying Table 2 lists the steady-state kinetic parameters for pET22.HPR tested positive in the ribonuclease plate the cleavage of poly(C) and the hydrolysis of C ú p by assay, indicating that this construct had the ability to recombinant HP-RNase produced in E. coli (reHPR.B), direct the expression of recombinant HP-RNase from HP-RNase from human pancreas, and RNase A. HPbacteria (reHPR.B).
RNase from E. coli displayed the same kinetic parameThe majority of reHPR.B produced by E. coli ters for each substrate tested as did HP-RNase from BL21(DE3) cells harboring pET22.HPR was not com-human pancreas and RNase A. pletely released from the periplasm upon cold osmotic shock. Rather, it was distributed among the soluble DISCUSSION and the insoluble fraction of the cell lysate. To extract all of the reHPR.B at once, the periplasmic contents
The study of HP-RNase has been impeded by the difficulty of isolating adequate amounts from human were released by cell lysis using solubilization buffer.
An isolation strategy based on refolding and reoxida-pancreas and by the extensive glycosylation of the human isolates. To reveal the atomic basis for the activition prior to purification, useful in the purification of RNase A produced by E. coli (22), was not useful in ties of HP-RNase, we found it necessary to develop a heterologous system for its production. We have accomthe isolation of reHPR.B. Removal of urea from the solubilized fraction by dialysis against an acidic buffer plished this goal by synthesizing a gene that codes for HP-RNase and producing the enzyme in both a yeast and the oxidation of the soluble dialysate with a glutathione redox buffer caused the precipitation of and a bacterial expression system.
In S. cerevisiae, HP-RNase is produced as a fusion reHPR.B along with other proteins. Hence, a purification step prior to an attempt to refold and reoxidize protein with the a-factor pre-pro segment. Although for some expressed proteins the presence of (Glu-Ala) 3 the solubilized reHPR.B was essential to isolate the recombinant enzyme. Reduced and unfolded reHPR.B sequence at the C-terminal of the leader peptide had on the post-translational processing, a fourfold improvement in the overall yield was observed when the peptide was present. This increase in production when using YEpHPR.2 could be explained by synergism in processing by the protease product of the gene STE13, which removes the (Glu-Ala) 3 nonapeptide, and the protease products of the KEX1 and KEX2 genes, which remove the C-terminal Lys-Arg sequence of the prepro sequence peptide and produce mature protein (43).
Recombinant HP-RNase produced in yeast cells transformed with YEpHPR.2 is recoverable at 0.1-0.2 mg/liter of culture. The active forms appeared as multiple bands in a zymogram. This heterogeneity, together with the existence of two additional N-glycosylation sites and the N-terminal basicity in the human enzyme, suggests, when these data are compared to those obtained for heterologous RNase A expressed in yeast (22), that reHPR.Y is processed inefficiently at its leader sequence and glycosylated extensively with Nlinked carbohydrates. In addition, reHPR.Y could be mildly glycosylated with O-linked carbohydrates. Such extensive glycosylation is not unusual in proteins produced in S. cerevisiae (45) . Further, simply replacing the Asn-Leu-Thr sequence of RNase A with an Asn- retic mobility. Thus, reHPR.Y produced using the pWL expression system is not the homogeneous enzyme required for rigorous structural or functional analysis. proved to be unnecessary for efficient secretion or proNevertheless, studies on protein glycosylation or subcessing (36,43), for other proteins the presence of this cellular localization by S. cerevisiae cells may benefit nonapeptide has been demonstrated to be crucial (44). from this system. We tried both approaches.
Plasmid pET22.HPR, derived from plasmid pET-HP-RNase isolated from the culture medium of S. 22b(/) (23) , directs the production of HP-RNase in E. cerevisiae cells harboring either YEpHPR.1 [which does coli (Fig. 2) . BL21(DE3) cells harboring pET22.HPR not code for (Glu-Ala) 3 ] or YEpHPR.2 [which codes for produced the heterologous enzyme in both a soluble the (Glu-Ala) 3 ] is a mixture of RNase species that difand insoluble form recoverable at 1 mg/liter of culture. fer in the extent of post-translational modification. Although the (Glu-Ala) 3 peptide had no apparent effect This isolate was shown to be homogeneous by electro- nant RNase A produced using a pET expression system 3. Raines, R. T., Toscano, M. P., Nierengarten, D. M., Ha, J. H., mid pET22.HPR is homogeneous. Although the mam-13. Beintema, J. J., Wietzes, P., Weickmann, J. L., and Glitz, D. G. malian system results in a threefold higher overall
